Tylenol maker pleads guilty over contaminated medications
McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, plead guilty this week to charges of selling medications contaminated with metal particles. Throughout 2008-2012, hundreds…
McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, plead guilty this week to charges of selling medications contaminated with metal particles. Throughout 2008-2012, hundreds of millions of products such as Tylenol, Motrin, Rolaids, Benadryl were recalled due to faulty manufacturing traced back to a Fort Washington, Pennsylvania plant.
Public alarm rose sharply in 2009, when a customer complained to Johnson & Johnson about strange, dark particles floating the bottom of an Infants’ Tylenol bottle.
SEE ALSO: Common and dangerous drug interactions you need to be aware of
At the time, the Food and Drug Administration announced a voluntary recall conducted by McNeil Consumer Healthcare of certain lots of oral suspension Children’s and Infants’ Tylenol products, but the reason cited was “due to the potential of bacteria in raw materials used to manufacture the finished product.”
The company’s analysis eventually revealed not only was there bacterial contamination in some batches; the particles in the medication were metal pieces of nickel and chromium.
From that time onward into 2012, millions of products were recalled, including the entire U.S. supply of children’s Tylenol. The recalls were not only the result of metal contamination; consumers reported other issues with Johnson & Johnson drugs such as strange odors, faulty dosing syringes and incorrect wording on labels.
The repercussions of the failed quality control for certain Johnson & Johnson products finally came to a head this year, when McNeil Consumer Healthcare plead guilty in federal court for the sale of potentially harmful products. The company will be fined $25 million, according to Reuters, and remittance of that fine will resolve the case legally.